Skip to content

Investigation of Effectiveness of Local Antibiotic With Platelet Rich Fibrin on Third Molar Surgery Outcomes In Vivo

Investigation of Effectiveness of Local Antibiotic Applications With Platelet Rich Fibrin on Third Molar Surgery Outcomes In Vivo and In Vitro

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05678296
Enrollment
60
Registered
2023-01-10
Start date
2020-04-20
Completion date
2022-04-23
Last updated
2023-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impacted Wisdom Tooth, Pain, Staphylococcus Aureus

Keywords

local antibiotic, comparison, platelets rich fibrin

Brief summary

The aim of this study was investigate the effectiveness of Local Antibiotic Applications With Platelet Rich Fibrin on Third Molar Surgery Outcomes In Vivo and In Vitro. The study included a total of 60 patients with impacted mandibular third molar. Patients were evaluated in 3 randomly separated groups. For the first and second group, Platelets Rich Fibrin+ local antibiotics were applied into the tooth socket. For the first group, amoxicillin was applied and for the second group, clindamycin was applied. There was a control group which only Platelets Rich Fibrin was applied into the socket. The outcome variables were pain, swelling, the number of analgesics taken, and trismus. These variables were also assessed based on first, second, third, and seventh days following the operation.

Interventions

DIAGNOSTIC_TESTDiagnosis

All of the patients withstand a radiological examination, including panoramic radiography, and all were handled by the same surgeon and assistant.

DRUGAnalgesic

Analgesics are prescribed for the patients for all groups.

In all groups the flap incision was triangular in shape which avoids muscle involvement (Archer flap).

BIOLOGICALPlatelet Rich Fibrin

Platelet rich fibrin (PRF), is an example and popular procedure for accelerate healing of soft and hard tissue because of the presence of various growth factors.a blood sample was taken without anticoagulant in 10 mL glass-coated plastic tubes that were immediately centrifuged (Elektro-mag M415P) at 3,000 rpm for 10 min (approximately 400 g) (13). The platelet-poor plasma that accumulated at the top of the tubes was discarded.PRF was dissected approximately 2 mm below its contact point with the red corpuscles situated beneath, to include any remaining platelets that may have localized below the junction between the PRF and red corpuscles.

DRUGAntibiotic

no systemic antibiotics are prescribed for the patients for all groups.

Sponsors

Ceren Melahat Donmezer
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* patient with no systemic diseases, no current infection, no smoke, no pregnancy

Exclusion criteria

* no inflammation

Design outcomes

Primary

MeasureTime frameDescription
visual analogue scale (VAS)Day 1It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured.
swellingDay 1measured using a flexible plastic measuring tape as described by Gabka and Matsumura by measuring the distance from the corner of the mouth to the attachment of the earlobe following the bulge of the cheek and the distance from the outer canthus of the eye to the angle of the mandible.
TrismusDay 1Trismus by measuring the distance between the mesial incisal corners of the upper and lower right incisors during maximum mouth opening.

Other

MeasureTime frameDescription
Amount of analgesic tabletsday 1,2,3,7 and 15Check the patients analgesic number of days 1,2,3,7 and 15.

Countries

Cyprus

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026